|
From
a pharmacological
standpoint, we have experience in reporting on the following
classes of medications:
- HMG CoA reductase inhibitors,
ACE inhibitors, calcium channel blockers, nicotinic acid derivatives
- various alpha- and beta-adrenergic
agents
- inhaled glucocorticoids
- protease inhibitors, nucleoside
and non-nucleoside reverse transcriptase inhibitors
- antineoplastic and immunosuppressive
agents
- bulk-forming laxatives
- prostaglandin analogs
- histamine and leukotriene
receptor antagonists
- selective serotonin re-uptake
inhibitors
- various NSAIDs, including
selective COX-2 inhibitors
- contraceptive agents and
hormone replacement therapies.
From a clinical
standpoint, we have experience with the following indications:
Cardiovascular
System: |
hypertension,
angina, congestive heart failure |
Digestive
System: |
ulcerative
colitis, Crohn’s disease, inflammatory bowel disease, gastroesophageal
reflux disease |
Infectious
disease: |
primarily
AIDS/HIV |
Metabolic
disorders: |
hypercholesterolemia,
hyperlipidemia |
Musculoskeletal
system: |
osteoarthritis
|
Nervous
system: |
depression,
anxiety, post-operative pain |
Oncology:
|
various
malignancies, including multiple myeloma, prostate cancer, and melanoma
|
Ophthalmic disorders: |
glaucoma,
ocular hypertension, allergic conjunctivitis, vernal keratoconjunctivitis |
Respiratory
system: |
asthma,
allergic rhinitis, chronic obstructive pulmonary disease
|
Urogenital
system: |
renal
failure, vaginitis, erectile dysfunction, postmenopausal symptoms,
pregnancy prevention |
|
|
 |